Gyre Therapeutics at Morgan Stanley conference: cash flow funds pipeline
Covered in this story
What has happened since
- Morgan Stanley is down 9.1% since this was published, 36 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $GYRE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Gyre Therapeutics Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.